vaginal disorders Flashcards

(32 cards)

1
Q

vulvovaginal candidiasis (VVC) causitive organisms?

A

Candida albicans

also Candida glabrata, Candida tropicalis, or Torulopsis glabrat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who gets VVC

A

At least 75% of women experience 1 episode

40-45% experience > 1 episode

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clinical presentation of VVC

A

Vulvar pruritis, external dysuria, burning, dyspareunia, swelling, redness, excoriation

Thick, curd-like vaginal dc

Normal vaginal pH <4.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RF’s for vulvovaginal candidiasis (VVC)

A

taking abx

immunocompromise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

dx for VVC

A

Clinical (consistent)

testing: 
wet prep (saline &amp; 10% KOH) --> buds and hyphae, candida culture, normal vag. ph (<4.5)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tx for uncomplicated VVC

A

short course (1–3d) of topical vaginal azole (clotrimazole OTC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tx for VVC in pregnancy

A

Topical azole x 7 days or single dose fluconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tx for complicated VVC

A

Recurrent (> 4 episodes in 1 yr), Severe, Non-albicans, Patient has uncontrolled DM or immune compromise

Tx w/ longer duration (7-14 days) topical azole or oral fluconazole (Diflucan)

If Non-albicans, avoid fluconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

should male partner be tx’d if female partner has VVC

A

No unless he has balanitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

in pt’s w/recurrent or difficult to tx yeast infx’s eval for…

A

DM, HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BV causative organism

A

Results from disruption of usual, “healthy” vaginal microflora (Lactobacillus sp) - allows overgrowth of bacteria

Cause is usu. polymicrobial - often assoc. with Gardnerella vaginalis & Mobiluncus sp (gram variable anaerobes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clinical presentation of BV

A

Vaginal irritation, thin white or gray discharge with strong fishy odor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

RF’s for BV

A

New or multiple sex partners, douche, rarely affects women who have never been sexually active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dx of BV

A

clinical (Amsel’s criteria)

best LAB test = gram stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is Amsel’s criteria?

A

3 of 4:

Thin white homogenous discharge that smoothly coats vaginal walls

Clue cells on microscopy

Vaginal fluid pH > 4.5

Release of fishy odor when adding KOH solution (+ whiff test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tx for BV

A

tx all pt’s w/sx’s
Metronidazole (Flagyl) orally for 7 days*

Metronidazole gel intravaginally x5d

Clindaymycin orally or intravaginally

pregnant - use oral meds

17
Q

complications of BV

A

Increases risk of acquiring & transmitting HIV

Increases risk of acquiring herpes, gonorrhea (GC) & chlamydia

Association with PID

Persistent/recurrent BV common

18
Q

what is atrophic vaginitis?

A

Loss of estrogen causes epithelial thinning involving the vulva, vagina and bladder (dryness)

loss of elasticity in connective tissue

19
Q

clinical presentation for atrophic vaginitis

A

Dyspareunia, post-coital bleeding, leukorrhea, burning, raw, dry sensation, urinary symptoms

“feels like a yeast infection”

20
Q

PE for atrophic vaginitis

A

Vagina has loss of rugae
Pale – red coloring, petechiae
Purulent vaginal discharge, fissures or erosions

Wet mount

pH > 5

21
Q

Tx for atrophic vaginitis

A

OTC vaginal moisturizer
(Replens) if CI’s to estrogen

Mechanical tx (stretch tissue)

vaginal estrogens (premarin or estrace vag cream, vagifem, estring)

Vaginal prasterone (DHEA)

Ospemifene (SERM)

22
Q

Vaginal intraepithelial neoplasia

A

incidence is 35-55

assoc. w/ CIN and squamous carcinoma of vulva/cervix

23
Q

RF’s for Vaginal intraepithelial neoplasia (VAIN)

A

Same as CIN:
Smoking, multiple sexual partners and early onset of sexual activity

Some women with 1 degree vaginal CA have NO h/o CIN III or cervical cancer

24
Q

pathogenesis for VAIN

A

HPV exposure

most lesions upper 1/3 of vagina

25
lab/studies for VAIN
detection is via pap smear (cytology) colposcopy
26
VAIN 1 managment:
Observation is justified in younger women Cytology/HPV/Colposcopy Q 6 months
27
VAIN 2/3 management
Surgical intervention vs. Topical chemotherapy
28
tx for VAIN
Vaginectomy | Laser Vaporization
29
when should you use topical chemotherapy for VAIN
if other tx's options are not feasible
30
Vaginal cancer
MCC of invasive CA is metastasis from endometrium, ovary or cervix
31
vaginal cancer clinical presentation
``` Asymptomatic Leukorrhea Vaginal odor Post-coital bleeding Abnormal Pap smea ```
32
vaginal cancer tx
no standard tx Combination of vaginectomy and radiation